Skip to content
2000
Volume 32, Issue 17
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

Cervical cancer originates in the cervix, the lower part of the uterus, and results from the uncontrolled growth of abnormal cervical cells, forming malignant tumours. It poses a major global health challenge, calling for innovative drug design strategies to enhance treatment outcomes.

Methods

In this study, we have screened the FDA-approved drug library against four proteins, MCM10, MCM6, DNA polymerase epsilon subunit-2, and TBK1, which are essential for DNA replication, DNA repair, and cellular signalling pathways, which are dysregulated in cervical cancer cells, leading to uncontrolled growth. We have used the multisampling algorithms for screening using HTVS, SP, and XP docking; identified 6-oxidopamine HBr (CHBrNO), which is used to create a model of Parkinson’s disease in animals, and obtained the docking score ranging from -5.057 to -8.871 Kcal/mol. The poses were filtered with MM\GBSA score ranging from -21.67 to -27.63 Kcal/mol. We performed QM-based DFT and pharmacokinetics studies and compared them with the standard values, suggesting that the compound can be used in cervical cancer proteins.

Results

The P-L complex’s interaction fingerprints have resulted in the most interacting residues, 4THR, 4SER, and 4LYS, showing the compound’s interaction pattern.

Conclusion

Further, the stability of 6-oxidopamine HBr in complex with each protein was evaluated with 100 ns MD simulation in the SPC water model in a neutralised state to analyse the deviation, fluctuations, and intermolecular interactions that have proven the compound to have a better inhibitory effect against each protein and that it can be used for cervical cancer; however, experimental validation is suggested before human use.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673289824240529063416
2024-06-13
2025-10-23
Loading full text...

Full text loading...

References

  1. KumawatG. VishwakarmaS.K. ChakrabartiP. ChittoraP. ChakrabartiT. LinJ.C-W. Prognosis of cervical cancer disease by applying machine learning techniques.J. Circuits Syst. Comput.2023321235001910.1142/S0218126623500196
    [Google Scholar]
  2. KarwasraR. AhmadS. BanoN. QaziS. RazaK. SinghS. VarmaS. Macrophage-targeted punicalagin nanoengineering to alleviate methotrexate-induced neutropenia: A molecular docking, DFT, and MD simulation analysis.Molecules20222718603410.3390/molecules2718603436144770
    [Google Scholar]
  3. KavithaR. Ant colony optimization-enabled CNN deep learning technique for accurate detection of cervical cancer.Biomed Res Int.20232023174289110.1155/2023/1742891
    [Google Scholar]
  4. PerkinsR.B. WentzensenN. GuidoR.S. SchiffmanM. Cervical cancer screening: A review.JAMA2023330654755810.1001/jama.2023.1317437552298
    [Google Scholar]
  5. AhmadS. Multitargeted molecular dynamic understanding of butoxypheser against SARS-CoV-2: An in silico study.Nat. Prod. Commun.20221771934578
    [Google Scholar]
  6. AhmadS. BhanuP. KumarJ. PathakR.K. MallickD. UttarkarA. NiranjanV. MishraV. Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid.Bioinformation202218317017910.6026/9732063001817036518123
    [Google Scholar]
  7. AhmadS. Mobile technology solution for COVID-19: Surveillance and prevention.Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and DiagnosisBerlin, HeidelbergSpringer202079108
    [Google Scholar]
  8. AhmadS. Therapeutic protein-based vaccines.Protein-based TherapeuticsBerlin, HeidelbergSpringer202335538410.1007/978‑981‑19‑8249‑1_13
    [Google Scholar]
  9. WarrenE.M. HuangH. FanningE. ChazinW.J. EichmanB.F. Physical interactions between Mcm10, DNA, and DNA polymerase α.J. Biol. Chem.200928436246622467210.1074/jbc.M109.02043819608746
    [Google Scholar]
  10. WeiZ. LiuC. WuX. XuN. ZhouB. LiangC. ZhuG. Characterization and structure determination of the Cdt1 binding domain of human minichromosome maintenance (Mcm) 6.J. Biol. Chem.201028517124691247310.1074/jbc.C109.09459920202939
    [Google Scholar]
  11. SuwaY. GuJ. BaranovskiyA.G. BabayevaN.D. PavlovY.I. TahirovT.H. Crystal structure of the human Pol α B subunit in complex with the C-terminal domain of the catalytic subunit.J. Biol. Chem.201529023143281433710.1074/jbc.M115.64995425847248
    [Google Scholar]
  12. ZhangC. ShangG. GuiX. ZhangX. BaiX. ChenZ.J. Structural basis of STING binding with and phosphorylation by TBK1.Nature2019567774839439810.1038/s41586‑019‑1000‑230842653
    [Google Scholar]
  13. AhmadS. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against cervical cancer.J. Biomol. Struct. Dyn.2022202211736379678
    [Google Scholar]
  14. AhmadS. Illustrious implications of nature-inspired computing methods in therapeutics and computer-aided drug design.Nature-Inspired Intelligent Computing Techniques in BioinformaticsNew YorkSpringer Link2022293308
    [Google Scholar]
  15. AhmadS. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: An optimisation followed multi-simulation and in-vitro study.J. Biomol. Struct. Dyn.2023202311837154501
    [Google Scholar]
  16. AlghamdiY.S. MashraqiM.M. AlzamamiA. AlturkiN.A. AhmadS. AlharthiA.A. AlshamraniS. AsiriS.A. Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: A virtual screening and molecular dynamics simulation study.J. Biomol. Struct. Dyn.202341146633664210.1080/07391102.2022.211015835971958
    [Google Scholar]
  17. AhmadS. Nanoinformatics and nanomodeling: Recent developments in computational nanodrug design and delivery systems.Emerging Nanotechnologies for Medical ApplicationsAmsterdam, NetherlandsElsevier2023297332
    [Google Scholar]
  18. AhmadS. Pasha KMM. RazaK. RafeeqM.M. HabibA.H. EswaranM. YadavM.K. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: An in silico study.J. Biomol. Struct. Dyn.20234194013402310.1080/07391102.2022.206030835451934
    [Google Scholar]
  19. AhmadS. RazaK. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: A multisampling algorithm-based structural study.Mol. Divers.2023202311410.1007/s11030‑023‑10648‑037058176
    [Google Scholar]
  20. SinghA.P. AhmadS. RazaK. GautamH.K. Computational screening and MM/GBSA-based MD simulation studies reveal the high binding potential of FDA-approved drugs against Cutibacterium acnes sialidase.J. Biomol. Struct. Dyn.2023202311137545341
    [Google Scholar]
  21. SinghD. VignatJ. LorenzoniV. EslahiM. GinsburgO. Lauby-SecretanB. ArbynM. BasuP. BrayF. VaccarellaS. Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO global cervical cancer elimination initiative.Lancet Glob. Health2023112e197e20610.1016/S2214‑109X(22)00501‑036528031
    [Google Scholar]
  22. TripathiM.K. Fundamentals of molecular modeling in drug design.Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based ApproachesAmsterdamElsevier202210.1016/B978‑0‑323‑90608‑1.00001‑0
    [Google Scholar]
  23. RamlalA. From molecules to patients: The clinical applications of biological databases and electronic health records.Translational bioinformatics in healthcare and medicine.Massachusetts, United StatesAcademic Press202110712510.1016/B978‑0‑323‑89824‑9.00009‑4
    [Google Scholar]
  24. RanaM. AhmediS. FatimaA. AhmadS. Nouman SiddiquiN. RazaK. ManzoorN. JavedS. Rahisuddin Synthesis, single crystal, TD-DFT, molecular dynamics simulation and DNA binding studies of carbothioamide analog.J. Mol. Struct.2023128713570110.1016/j.molstruc.2023.135701
    [Google Scholar]
  25. JorgensenW.L. Tirado-RivesJ. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.J. Am. Chem. Soc.198811061657166610.1021/ja00214a00127557051
    [Google Scholar]
  26. SchrödingerLife Science: Maestro - Schrödinger.2022Available From: https://newsite.schrodinger.com/platform/products/maestro/
  27. SchrödingerLigPrep2022Available from: https://schrodinger.com/
  28. ShahA.A. Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis.Curr. Med. Chem.202331559561936892124
    [Google Scholar]
  29. SheikhK. Consequential innovations in nature-inspired intelligent computing techniques for biomarkers and potential therapeutics identification.Nature-Inspired Intelligent Computing Techniques in BioinformaticsBerlin, HeidelbergSpringer2022247274
    [Google Scholar]
  30. ShelleyJ.C. CholletiA. FryeL.L. GreenwoodJ.R. TimlinM.R. UchimayaM. Epik: A software program for pK a prediction and protonation state generation for drug- like molecules.J. Comput. Aided Mol. Des.2007211268169110.1007/s10822‑007‑9133‑z17899391
    [Google Scholar]
  31. AlturkiN.A. MashraqiM.M. AlzamamiA. AlghamdiY.S. AlharthiA.A. AsiriS.A. AhmadS. AlshamraniS. In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2.Molecules20222714439110.3390/molecules2714439135889265
    [Google Scholar]
  32. AlzamamiA. AlturkiN.A. AlghamdiY.S. AhmadS. AlshamraniS. AsiriS.A. MashraqiM.M. Hemi-Babim and fenoterol as potential inhibitors of MPro and papain- like protease against SARS-CoV-2: An in silico study.Medicina (Kaunas)202258451510.3390/medicina5804051535454354
    [Google Scholar]
  33. BermanH. The Protein Data Bank.Nucleic Acids Res.200028123542
    [Google Scholar]
  34. SchrödingerProtein Preparation Wizard.2022Available from: https://schrodinger.com/
  35. JacobsonM.P. PincusD.L. RappC.S. DayT.J.F. HonigB. ShawD.E. FriesnerR.A. A hierarchical approach to all-atom protein loop prediction.Proteins200455235136710.1002/prot.1061315048827
    [Google Scholar]
  36. YadavM.K. Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2.J. Biomol. Struct. Dyn.2022202211334974820
    [Google Scholar]
  37. FriesnerR.A. MurphyR.B. RepaskyM.P. FryeL.L. GreenwoodJ.R. HalgrenT.A. SanschagrinP.C. MainzD.T. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.J. Med. Chem.200649216177619610.1021/jm051256o17034125
    [Google Scholar]
  38. Schrödinger2022Available from: https://schrodinger.com/
  39. LipinskiC.A. Lead- and drug-like compounds: The rule-of-five revolution.Drug Discov. Today. Technol.20041433734110.1016/j.ddtec.2004.11.00724981612
    [Google Scholar]
  40. SchrödingerQikProp2022Available from: https://schrodinger.com/
    [Google Scholar]
  41. BochevarovA.D. HarderE. HughesT.F. GreenwoodJ.R. BradenD.A. PhilippD.M. RinaldoD. HallsM.D. ZhangJ. FriesnerR.A. Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences.Int. J. Quantum Chem.2013113182110214210.1002/qua.24481
    [Google Scholar]
  42. BowersK.J. Scalable algorithms for molecular dynamics simulations on commodity clusters.Proceedings of the 2006 ACM/IEEE Conference on Supercomputing11-17 November 2006, Tampa, FL, USA, 200610.1109/SC.2006.54
    [Google Scholar]
  43. JorgensenW.L. Convergence of Monte Carlo simulations of liquid water in the NPT ensemble.Chem. Phys. Lett.198292440541010.1016/0009‑2614(82)83437‑4
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673289824240529063416
Loading
/content/journals/cmc/10.2174/0109298673289824240529063416
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test